Exchange: NASDAQ·Updated 07:44 PM EDT

About TLX

About

Telix Pharmaceuticals Ltd. is a biopharmaceutical company, which engages in the development and commercialization of several clinical-stage oncology assets. The firm operates through the following segments: Therapeutics (Tx), Precision Medicine (Px), and Telix Manufacturing Solutions (TMS). The Tx segment focuses on development of targeted radionuclide therapies for urologic and neurologic oncology, and other solid tumors. The Px segment includes provision of diagnostic imaging solutions to market and expanding into new geographies and indications. The TMS segment comprises of costs to operate the firm's facilities and assets. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East and Africa. The company was founded by Andreas Kluge and Christian P. Behrenbruch in November 2015 and is headquartered in North Melbourne, Australia.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
1,184

Frequently Asked Questions

What is Market Cap of Telix Pharmaceuticals Ltd. - ADR?
What is the 52-week high for Telix Pharmaceuticals Ltd. - ADR?
What is the 52-week low for Telix Pharmaceuticals Ltd. - ADR?
What is Telix Pharmaceuticals Ltd. - ADR stock price today?
What was Telix Pharmaceuticals Ltd. - ADR stock price yesterday?
What is the PE ratio of Telix Pharmaceuticals Ltd. - ADR?
What is the Price-to-Book ratio of Telix Pharmaceuticals Ltd. - ADR?
What is the 50-day moving average of Telix Pharmaceuticals Ltd. - ADR?
How many employees does Telix Pharmaceuticals Ltd. - ADR have?

Advertisement|Remove ads.